Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

The Upper Austrian startup GENSPEED® Biotech develops a rapid test system for hospital bacteria and periodontal pathogens

GENSPEED®-Technology © GENSPEED® Biotech GmbH

Infections caused by antibiotic-resistant hospital bacteria that occur during hospital stays or infections with periodontal pathogens can result in serious consequences for affected patients. Both the detection of hospital bacteria in hospitals and the detection of periodontal pathogens in the dental field can take several days. The patient samples must either be examined through the use of lengthy in-house analyses or sent to external laboratories. With the rapid tests from GENSPEED® Biotech, hospital bacteria can be detected in the hospital laboratory in just 100 minutes, and periodontal pathogens can be detected in just 20 minutes directly at the dentist's practice. In both cases, rapid diagnosis allows for an immediate, targeted start of treatment. The GENSPEED immediate diagnosis system is a patented technology based on microfluid biochips, miniaturized optical detection and automation. In other words, the sample (e.g. from a nasal smear) is processed using standard methods and dripped into a so-called microfluid chip. No further intervention is required by the user, who can read the test result on the computer after a short time.

 

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us at: Day of the Regions of the Russian Federation in the WKÖ

    25.03.2019, Vienna, Austria

  • L'open day Austria

    02.04.2019, Bologna, Italy

Austria Map

Find the perfect location for your company

Austria stands out due to its long-term reliable and stable conditions. These
features are particularly important for a research-based company such as
Boehringer Ingelheim. Furthermore, Vienna is a city with a good research
infrastructure and a high quality of life, and is thus also an interesting place
for highly qualified employees from Austria and abroad.

Boehringer Ingelheim

Logo
More testimonials

news from the business location Austria

Startup Report Austria 2018: An Overview of Key Findings

This week Florian Kandler presented his Startup Report Austria 2018. The results of the current issue of the annually published report are consistently positive. In a guest commentary for derBrutkasten Kandler selected several highlights of the report.

Startups in an enterprise environment - how companies can profit from startups

The age of digital transformation and the approach of Industry 4.0 designed to accelerate the fourth industrial revolution open up opportunities in fields such as artificial intelligence (AI) and the Internet of Things (IoT). The run towards digital business models, the collaboration with startups and the development of new innovation driver models has also impacted large European companies. Here you can read about why big firms suddenly place so much hope in startups and what they are doing.

More news All blog posts